Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low‐HIV prevalence, low‐resource setting-Reference-Cited by-同舟云学术

Cost analysis of centralized viral load testing for antiretroviral therapy monitoring in Nicaragua, a low‐HIV prevalence, low‐resource setting

Published:2010-01 Issue:1 Volume:13 Page:43-43
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:Journal of the International AIDS Society

Author:

Gerlach Jay¹,Sequeira Magda²,Alvarado Vivian²,Cerpas Christian³,Balmaseda Angel³,Gonzalez Alcides³,Santos Tala¹,Levin Carol E¹,Amador Juan Jose²,Domingo Gonzalo J¹

Affiliation:

1. Programs for Appropriate Technologies in Health (PATH), Seattle, Washington 98121, USA

2. PATH, Managua, Nicaragua

3. Centro Nacional de Diagnóstico y Referencia, Costado Oeste Colonia Primero de Mayo, Managua, Nicaragua

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/1758-2652-13-43

Reference29 articles.

1. Cost-Effectiveness of HIV Treatment in Resource-Poor Settings — The Case of Côte d'Ivoire

2. Expanding Antiretroviral Options in Resource-Limited Settings-A Cost-Effectiveness Analysis

3. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings

4. Cost‐effectiveness of highly active antiretroviral therapy in South Africa;Badri M;PLoS Med,2006

5. Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the performance of a multiplex reverse transcription polymerase chain reaction kit as a potential diagnostic and surveillance kit for rotavirus in Kenya;Tropical Diseases, Travel Medicine and Vaccines;2019-07-15

2. Use of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican Patients;BioMed Research International;2015

3. Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants;Clinical and Vaccine Immunology;2014-01-08

4. Cost-Effectiveness of Improving Health Care to People with HIV in Nicaragua;Nursing Research and Practice;2014

5. Progress in the development of paper-based diagnostics for low-resource point-of-care settings;Bioanalysis;2013-11